DiaMedica Therapeutics Inc (DMAC) insider trading
Every open-market stock purchase and sale by DiaMedica Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $7.6M over the last 12 months (1 buy).
- Last insider buy: Jan Stahlberg (10% owner), $627K, 10 months ago.
Last 12 months: insiders bought $7.6M (1 buy) and sold $0 (0 sales). Last close $6.68 on Aug 14, 2026.
Recent DMAC insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | Dietrich John Pauls (CEO) | Bought (not open market) | — |
| Jun 1, 2026 | Tanya Lewis (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Randall Michael Giuffre (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Daniel J. O'Connor (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Richard Kuntz (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Julie Krop (C-suite exec) | Bought (not open market) | — |
| Jun 1, 2026 | Charles Pauling Semba (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Dietrich John Pauls (CEO) | Bought (not open market) | — |
| Jun 1, 2026 | Scott Kellen (CFO) | Bought (not open market) | — |
| Jun 1, 2026 | James T. Parsons (Insider) | Bought (not open market) | — |
| Jan 2, 2026 | James T. Parsons (Insider) | Bought (not open market) | $85K |
| Jan 2, 2026 | Randall Michael Giuffre (Insider) | Bought (not open market) | $52K |
| Jan 2, 2026 | Charles Pauling Semba (Insider) | Bought (not open market) | $28.2K |
| Nov 25, 2025 | Jan Stahlberg (10% owner) | Bought | $627K |
| Nov 24, 2025 | Jan Stahlberg (10% owner) | Bought | $318K |
| Nov 21, 2025 | Jan Stahlberg (10% owner) | Bought | $1.5M |
| Nov 21, 2025 | James T. Parsons (Insider) | Bought (not open market) | — |
| Nov 20, 2025 | Jan Stahlberg (10% owner) | Bought | $951K |
| Nov 19, 2025 | Jan Stahlberg (10% owner) | Bought | $1.7M |
| Nov 18, 2025 | Jan Stahlberg (10% owner) | Bought | $1.2M |
| Nov 17, 2025 | Jan Stahlberg (10% owner) | Bought | $1.2M |
Who's trading DMAC
- Dietrich John Pauls, CEO: other filings, last Aug 10, 2026
- Randall Michael Giuffre, Director: other filings, last Jun 1, 2026
- Scott Kellen, CFO: other filings, last Jun 1, 2026
- Julie Krop, C-suite exec: other filings, last Jun 1, 2026
- Richard Kuntz, Director: other filings, last Jun 1, 2026
- Tanya Lewis, Director: other filings, last Jun 1, 2026
- Charles Pauling Semba, Director: other filings, last Jun 1, 2026
- Daniel J. O'Connor, Director: other filings, last Jun 1, 2026
- James T. Parsons, Director: other filings, last Jun 1, 2026
- Jan Stahlberg, 10% owner: bought $7.6M (7 buys), last Nov 25, 2025
Get free alerts when an insider at DiaMedica Therapeutics Inc files a new trade →